HTR3D
Basic information
Region (hg38): 3:184031544-184039369
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HTR3D gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 33 | 9 | 0 |
Variants in HTR3D
This is a list of pathogenic ClinVar variants found in the HTR3D region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-184031760-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
3-184031766-A-G | not specified | Likely benign (Apr 25, 2023) | ||
3-184032841-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
3-184032859-C-G | not specified | Uncertain significance (Jan 26, 2023) | ||
3-184032870-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
3-184032928-G-C | not specified | Uncertain significance (Oct 26, 2022) | ||
3-184032933-G-C | not specified | Uncertain significance (May 04, 2023) | ||
3-184033023-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
3-184035174-C-G | not specified | Uncertain significance (May 03, 2023) | ||
3-184035174-C-T | not specified | Uncertain significance (Mar 11, 2022) | ||
3-184035988-C-T | not specified | Likely benign (Feb 28, 2023) | ||
3-184035991-C-G | not specified | Uncertain significance (May 04, 2022) | ||
3-184035998-A-G | not specified | Uncertain significance (Nov 18, 2023) | ||
3-184036003-C-A | not specified | Uncertain significance (Apr 24, 2024) | ||
3-184036014-G-A | not specified | Likely benign (Oct 02, 2023) | ||
3-184036034-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
3-184036043-A-G | not specified | Likely benign (Mar 19, 2024) | ||
3-184036048-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
3-184036054-A-G | not specified | Uncertain significance (Aug 02, 2023) | ||
3-184036084-G-A | not specified | Likely benign (Aug 30, 2021) | ||
3-184036093-G-A | not specified | Uncertain significance (Mar 28, 2023) | ||
3-184036377-T-A | not specified | Uncertain significance (Jan 26, 2022) | ||
3-184036382-C-A | not specified | Uncertain significance (Sep 09, 2021) | ||
3-184036464-C-A | not specified | Uncertain significance (Feb 26, 2024) | ||
3-184036751-G-A | not specified | Uncertain significance (Mar 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HTR3D | protein_coding | protein_coding | ENST00000382489 | 8 | 7826 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.02e-8 | 0.402 | 38094 | 27001 | 60650 | 125745 | 0.450 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.654 | 226 | 255 | 0.885 | 0.0000134 | 2926 |
Missense in Polyphen | 36 | 51.25 | 0.70244 | 745 | ||
Synonymous | 0.592 | 98 | 106 | 0.927 | 0.00000614 | 936 |
Loss of Function | 0.771 | 13 | 16.4 | 0.794 | 7.78e-7 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 1.10 | 1.09 |
Ashkenazi Jewish | 0.578 | 0.578 |
East Asian | 0.496 | 0.494 |
Finnish | 0.318 | 0.316 |
European (Non-Finnish) | 0.442 | 0.442 |
Middle Eastern | 0.496 | 0.494 |
South Asian | 0.452 | 0.450 |
Other | 0.468 | 0.472 |
dbNSFP
Source:
- Function
- FUNCTION: This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor is a ligand-gated ion channel, which when activated causes fast, depolarizing responses. It is a cation-specific, but otherwise relatively nonselective, ion channel.;
- Pathway
- Serotonergic synapse - Homo sapiens (human);Taste transduction - Homo sapiens (human);Neuronal System;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses
(Consensus)
Intolerance Scores
- loftool
- 0.305
- rvis_EVS
- 2.51
- rvis_percentile_EVS
- 98.66
Haploinsufficiency Scores
- pHI
- 0.158
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.111
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- signal transduction;serotonin receptor signaling pathway;chemical synaptic transmission;ion transmembrane transport;regulation of membrane potential;nervous system process
- Cellular component
- plasma membrane;integral component of plasma membrane;neuron projection;synapse
- Molecular function
- transmembrane signaling receptor activity;extracellular ligand-gated ion channel activity;protein binding;serotonin-gated cation-selective channel activity